LILRA1 Protein - ACROBiosystems

Home
Products

products by category

Recombinant proteins
Fc receptor proteins FcRn Proteins IL-6 and IL-6 Receptor Proteins IgG Fc Proteins (Isotype Control) Immune checkpoint proteins Targets of CAR-T cell therapy New Generation Tools for CAR DetectionStar Staining FDA DMF filed proteins Multi-pass TpsHot ADC targets BsAb targets TME pathway targets CytokinesHot Enzymes Llama IgG Fc fusion protein Biosimilar drug targets Biomarkers & CD antigens All recombinant proteins

Antibodies
Anti-idiotypic antibody Anti-FMC63 mAb Neutralizing antibodies
Kits
Pre-coupling magnetic beads Inhinitor screening kits ELISA Assay Kits for Quantitative analysis of therapeutic antibodies in serum
Supports on COVID-19 R&DHot
SARS-CoV-2 related products SARS-CoV-2 mutant products SARS-CoV-2 related kits Reagents for vaccine development Reagents for diagnostic development

Featured products

Pre-labeled proteins
New Generation Tools for CAR DetectionStar Staining Biotinylated protein collection FITC & PE labeled proteins
Full-length multi-pass TpsHot
Multi-pass Tps Claudin 18.2 GPCRs CD20 proteins

Hot targets
CD19 BCMA CD3 proteins IL-2 receptors Claudin 18.2 GPCRs CD20 proteins CD39/CD73 proteins B7 families TNFSF proteins VEGF proteins PD1 proteins TIGIT Siglec-15 proteins Integrin CD24&siglec-10
Services

Innovation Lab
SPR /BLI analytical serviceNew Enzyme-Linked Immunosorbent Assay (ELISA) Service New Meso Scale Discovery (MSD) ServiceNew Anti-Idiotypic Antibody Development ServiceNew Pseudovirus Neutralization Assay ServiceNew

Licensing Opportunities
Target 4-1BB monoclonal antibody New PD-1/CD80 bispecific antibodyNew Antagonizing TSP1/CD36 Polypeptide Blocking the activation of TGF-β1New Anti-PD-L1 / TIGIT bispecific antibodyNew TIGIT-Fc proteinNew Novel small molecule drug for cancer cachexiaNew
Supports

How to Order Shipping & Payments Global Distributors Testimonials FAQs Download COA
Applications

The Process of How SARS-CoV-2 Infects the Host Quantitative Analysis of mAb in Serum Evaluation of CAR Expression
News

News Insights Promotions Exhibitions
Resources

Download Brochures Download E-resources Download COA
ACROBiosystems

About Us Join Us Contact Us

LILRA1


LI1-H82E8	Human	Biotinylated Human LILRA1 / CD85i / LIR-6 Protein, His,Avitag™

Cat. No.

Species

Product Description

Structure

Purity

Feature

LI1-H82E8

Human

Biotinylated Human LILRA1 / CD85i / LIR-6 Protein, His,Avitag™

Part of Bioactivity data

LI1-H82E8-MALS-HPLC

Loaded Biotinylated Human LILRA1, His,Avitag (Cat. No. LI1-H82E8) on SA Biosensor, can bind Human ANGPTL7, His Tag (Cat. No. AN7-H52H5) with an affinity constant of 0.204 μM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

Protocol

Synonym Name

LILRA1,LIR6,CD85i,LIR-6

Background

Leukocyte immunoglobulin-like receptors (LILRs) are inhibitory, stimulatory or soluble receptors encoded within the leukocyte receptor complex. Some LILRs are extensively polymorphic, and exhibit evidence for balancing selection and association with disease susceptibility. LILRA1 (LIR-6) can recognize MHC (major histocompatibility complex) class I or class I-like molecules, and high levels of sequence similarity among LILRA1, LILRA2 (ILT1), LILRA3 (ILT6) and LILRB1/B2.

Clinical and Translational Updates